Insmed Incorporated

INSMBiotechnologyClosed

93.42-0.1%Up to 1000x leverageTrade INSM

What it reported

Reported 81 days ago, on 2026-08-06.

EPS against forecast+91.1%
Revenue against forecast+7.6%
Share price, two sessions+32.5%

Forecast against the result

ForecastReportedSurprise
Revenue395.5M425.5M+296.1% year on year+7.6%
Net income-146.1M-13.2M+95.9% year on year+90.9%
Earnings per share-0.67-0.06+96.5% year on year+91.1%

Year on year compares the same quarter a year earlier (2025-08-07), not the quarter before.

INSM trades at up to 1000x here. At 1000x, a 0.10% move against you wipes out the whole margin. This ignores fees, funding and maintenance margin, all of which bring liquidation forward. Your actual liquidation price is the one shown on the order page.

You can hold through the announcement here

INSM is quoted here 24 hours a day and does not stop when the US market closes. On a US exchange the same news only shows up as a gap at the next open.

What the market expects

For the quarter ending 2026-09-30.

EPS forecast13 analysts
-0.39
-0.51-0.15
Revenue forecast14 analysts
499.1M
493.8M512.5M
Net income
-84.3M
-111.6M-32.2M
EBITDA
-57.8M
-85.1M-5.7M

Against the same quarter last year (2025-10-30): EPS +77.8%revenue +250.6%

These are third-party analyst forecasts. CoinUnited.io does not produce them and does not choose which analysts are included.

Track record

Next report expected 2026-10-29. Reports quarterly.

Beat estimates 2 of the last 8 quarters. The typical gap is -0.12 per share.

How much it actually moves

±6.8%

Median move across the two sessions around the report, over its last 8 results. On an ordinary two-day stretch it moves 1.9%.

2026-08-06+32.51%

Beat or miss, then up or down

RoseFell
Beat11
Missed24

Counted across 8 results. This is what happened, not what will.

Where analysts put it in 12 months

A different timescale from the rest of this page: these are 12-month views, not the two-day move around a report.

Lowest169.00
Median192.00
Highest235.00
FirmTargetSet onSource
Morgan Stanley213.002026-10-21TheFly
Raymond James173.002026-10-20TheFly
Barclays207.002026-09-30TheFly
Goldman Sachs188.002026-09-24TheFly
Roth Capital198.002026-09-15TheFly
Truist Financial195.002026-08-10TheFly
Evercore ISI170.002026-08-07TheFly
Guggenheim205.002026-08-07TheFly
UBS172.002026-08-07TheFly
Wells Fargo169.002026-08-07TheFly
Jefferies175.002026-08-06TheFly
Cantor Fitzgerald235.002026-07-28StreetInsider
BMO Capital192.002026-07-20TheFly
H.C. Wainwright220.002026-07-20StreetInsider
Mizuho Securities192.002026-06-16StreetInsider

From 15 firms that published a target in the last 180 days, latest call per firm. Targets are set by those firms; CoinUnited.io does not produce or endorse them.

Reported results

ReportedEPS forecastEPS actualSurpriseRevenue surprise
2026-08-06-0.6724-0.06+91.1%+7.6%
2026-05-07-0.9634-0.76+21.1%+1.7%
2026-02-19-1.07-1.54-43.9%+14.1%
2025-10-30-1.33-1.75-31.6%+23.3%
2025-08-07-1.3-1.7-30.8%+3.2%
2025-05-08-1.34-1.42-6.0%+1.5%
2025-02-20-1.17-1.32-12.8%+2.3%
2024-10-31-1.2-1.27-5.8%+0.1%
2024-08-08-1.24-1.94-56.5%+2.7%
2024-05-09-1.24-1.06+14.5%-2.9%
2024-02-22-1.13-1.28-13.3%+1.6%
2023-10-26-1.06-1.1-3.8%-0.1%

Also reporting this fortnight in Biotechnology

2 more in Biotechnology

EPS history for INSM runs from 1999-03-31 to 2026-08-06, 83 reports.Reaction history covers its last 8 results, which is as deep as our daily price baseline reaches.